Presentation (CTI)

OBJECTIVES: The objective of this essay is to analyze drug price regulation in Peru, identifying progress, limitations, and outstanding challenges, in light of the international context and experience, as well as local progress.
METHODS: A narrative review was conducted to support the critical essay, which was organized into three main sections. The first section presents an overview of drug price regulation mechanisms implemented internationally, with an emphasis on lessons that could be applied to the Peruvian context. The second section analyzes the current state of price regulation in Peru, identifying its scope and regulatory aspects. The third section examines the potential and actual impacts of these measures in terms of access, equity, and the sustainability of the healthcare system.
RESULTS: While progress has been made in transparency and regulatory availability, such as the Price Observatory, the provision for generic drugs in pharmacies nationwide, and prescription by International Nonproprietary Name (INN), these measures remain fragmented and insufficient. The lack of robust centralized negotiation mechanisms, market concentration, and mistrust of generic drugs limit regulatory capacity, perpetuating equity gaps.
CONCLUSIONS: In conclusion, drug price regulation in Peru has brought structural problems to light, but it has not corrected them. Furthermore, it requires political will, a coherent regulatory framework, and rigorous implementation that integrates technical criteria with social needs.